Time-dependent changes in the plasma amino acid concentration in diabetes mellitus

Molecular Genetics and Metabolism

Volumn 103, Issue 4, 2011, Pages 406-409

  Mochida, Taiga ^a   Tanaka, Takayuki ^b   Shiraki, Yasuko ^a   Tajiri, Hiroko ^a   Matsumoto, Shirou ^a   Shimbo, Kazutaka ^b   Ando, Toshihiko ^b   Nakamura, Kimitoshi ^a   Okamoto, Masahiro ^c   Endo, Fumio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

AKITA mouse; Diabetes mellitus; Insulin deficiency; Longitudinal change; Plasma amino acid

Indexed keywords

ALANINE; CITRULLINE; GLUCOSE; ISOLEUCINE; LEUCINE; PROLINE; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE; AMINO ACIDS; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; INSULIN; ISOLEUCINE; LEUCINE; LONGITUDINAL STUDIES; MICE; MICE, INBRED STRAINS;

MUS;

EID: 79960840896     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.05.002     Document Type: Article

References (22)

1. Wilcken B., Wiley V., Hammond J., Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N. Engl. J. Med. 2003, 348:2304-2312.
2. Morgan M.Y., Milsom J.P., Sherlock S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 1978, 19:1068-1073.
3. Vente J.P., von Meyenfeldt M.F., van Eijk H.M., van Berlo C.L., Gouma D.J., van der Linden C.J., Soeters P.B. Plasma-amino acid profiles in sepsis and stress. Ann. Surg. 1989, 209:57-62.
4. Norton J.A., Gorschboth C.M., Wesley R.A., Burt M.E., Brennan M.F. Fasting plasma amino acid levels in cancer patients. Cancer 1985, 56:1181-1186.
5. Hebert S.L., Nair K.S. Protein and energy metabolism in type 1 diabetes. Clin Nutr 2010, 29:13-17.
6. Kayo T., Koizumi A. Mapping of murine diabetogenic gene mody on chromosome 7 at D7Mit258 and its involvement in pancreatic islet and beta cell development during the perinatal period. J. Clin. Invest. 1998, 101:2112-2118.
7. Oyadomari S., Koizumi A., Takeda K., Gotoh T., Akira S., Araki E., Mori M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 2002, 109:525-532.
8. Wang J., Takeuchi T., Tanaka S., Kubo S.K., Kayo T., Lu D., Takata K., Koizumi A., Izumi T. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J. Clin. Invest. 1999, 103:27-37.
9. Haseyama T., Fujita T., Hirasawa F., Tsukada M., Wakui H., Komatsuda A., Ohtani H., Miura A.B., Imai H., Koizumi A. Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse Tohoku. J. Exp. Med. 2002, 198:233-244.
10. Hong E.G., Jung D.Y., Ko H.J., Zhang Z., Ma Z., Jun J.Y., Kim J.H., Sumner A.D., Vary T.C., Gardner T.W., Bronson S.K., Kim J.K. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1687-E1696.
11. Schmidt R.E., Green K.G., Snipes L.L., Feng D. Neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia. Exp. Neurol. 2009, 216:207-218.
12. Shimbo K., Oonuki T., Yahashi A., Hirayama K., Miyano H. Precolumn derivatization reagents for high-speed analysis of amines and amino acids in biological fluid using liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:1483-1492.
13. Noguchi Y., Sakai R., Kimura T. Metabolomics and its potential for assessment of adequacy and safety of amino acid intake. J. Nutr. 2003, 133:097S-2100S.
14. Robert J.J., Beaufrere B., Koziet J., Desjeux J.F., Bier D.M., Young V.R., Lestradet H. Whole body de novo amino acid synthesis in type I (insulin-dependent) diabetes studied with stable isotope-labeled leucine, alanine, and glycine. Diabetes 1985, 34:67-73.
15. Shulman G.I., Lacy W.W., Liljenquist J.E., Keller U., Williams P.E., Cherrington A.D. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. J. Clin. Invest. 1980, 65:496-505.
16. Vannini P., Marchesini G., Forlani G., Angiolini A., Ciavarella A., Zoli M., Pisi E. Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1982, 22:217-219.
17. Hutson S.M., Harper A.E. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease. Am. J. Clin. Nutr. 1981, 34:173-183.
18. Aftring R.P., Miller W.J., Buse M.G. Effects of diabetes and starvation on skeletal muscle branched-chain alpha-keto acid dehydrogenase activity. Am. J. Physiol. 1988, 254:E292-E300.
19. Kowaloff E.M., Phang J.M., Granger A.S., Downing S.J. Regulation of proline oxidase activity by lactate. Proc Natl Acad Sci USA 1977, 74:5368-5371.
20. Ido Y., Kilo C., Williamson J.R. Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 1997, 40(Suppl 2):S115-S117.
21. Levillain O., Parvy P., Hassler C. Amino acid handling in uremic rats: citrulline, a reliable marker of renal insufficiency and proximal tubular dysfunction. Metabolism 1997, 46:611-618.
22. Szabo A., Kenesei E., Korner A., Miltenyi M., Szucs L., Nagy I. Changes in plasma and urinary amino acid levels during diabetic ketoacidosis in children. Diabetes Res. Clin. Pract. 1991, 12:91-97.